InvestSMART

BCAL Diagnostics Limited (ASX: BDX) - Announcements

Current share price for BDX : $0.090 0.001 (1.10%)+

ASX company news and announcements for BCAL Diagnostics Limited (BDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BCAL Diagnostics Limited (BDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BCAL Diagnostics Limited (BDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BCAL Diagnostics Limited (BDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$33 Application for quotation of securities - BDX 18 Sep 2023 6:45PM $0.115 $0.090 fallen by 21.74%
$33 Application for quotation of securities - BDX 18 Sep 2023 6:42PM $0.115 $0.090 fallen by 21.74%
$33 BCAL Share Purchase Plan Closes 18 Sep 2023 11:05AM $0.120 $0.090 fallen by 25%
$33 BCAL Locks Down Crucial Breast Cancer Signature 11 Sep 2023 12:44PM $0.100 $0.090 fallen by 10%
$33 Change in substantial holding 5 Sep 2023 11:44AM $0.098 $0.090 fallen by 8.16%
$33 Shane Ryan Appointed Chief Operating Officer 5 Sep 2023 8:16AM $0.100 $0.090 fallen by 10%
$33 Cleansing Notice 1 Sep 2023 3:46PM $0.100 $0.090 fallen by 10%
$33 Application for quotation of securities - BDX 1 Sep 2023 11:52AM $0.100 $0.090 fallen by 10%
$33 Preliminary Final Report 30 Aug 2023 8:06AM $0.100 $0.090 fallen by 10%
$33 Share Purchase Plan Offer Booklet 30 Aug 2023 8:05AM $0.100 $0.090 fallen by 10%
$33 Proposed issue of securities - BDX 29 Aug 2023 10:05AM $0.100 $0.090 fallen by 10%
$33 $2.4m Capital Raise to Further BREASTEST Commercialisation 28 Aug 2023 8:50AM $0.115 $0.090 fallen by 21.74%
$33 BCAL Presentation August 2023 24 Aug 2023 2:56PM $0.115 $0.090 fallen by 21.74%
$33 Trading Halt 24 Aug 2023 9:43AM $0.115 $0.090 fallen by 21.74%
$33 Application for quotation of securities - BDX 11 Aug 2023 6:41PM $0.130 $0.090 fallen by 30.77%
$33 Notification of cessation of securities - BDX 11 Aug 2023 6:41PM $0.130 $0.090 fallen by 30.77%
$33 Application for quotation of securities - BDX 10 Aug 2023 8:55AM $0.140 $0.090 fallen by 35.71%
$33 BCAL Investor Education Update & Webinar 8 Aug 2023 9:56AM $0.145 $0.090 fallen by 37.93%
$33 Breakthrough Results a Major Step Towards Commercialisation 2 Aug 2023 8:28AM $0.080 $0.090 risen by 12.50%
$33 Application for quotation of securities - BDX 28 Jul 2023 6:57PM $0.070 $0.090 risen by 28.57%
$33 Shares and Options Released from Escrow 28 Jul 2023 6:56PM $0.070 $0.090 risen by 28.57%
$33 Quarterly Activities/Appendix 4C Cash Flow Report 27 Jul 2023 8:36AM $0.070 $0.090 risen by 28.57%
$33 Shareholder Newsletter 20 Jul 2023 9:16AM $0.070 $0.090 risen by 28.57%
$33 Notification regarding unquoted securities - BDX 30 Jun 2023 8:41AM $0.070 $0.090 risen by 28.57%
$33 Proposed issue of securities - BDX 30 Jun 2023 8:34AM $0.070 $0.090 risen by 28.57%

176 - 200 of 277 results

Page 8 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.